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Available online at www.jcmm.ro www.jcmm.org JCMM JCMM doi:10.2755/jcmm010.004.14 tractility provided by α smooth muscle actin (SMA) fiber formation leading to constriction of sinusoidal blood flow; and increased synthesis and release of fibrillar collagens [2] . Therapeutic approaches aim to suppress activation of HSCs. One promising route is to antagonize profibrogenic signaling of transforming growth factor β (TGF-β) [3, 4] . TGF-β family members control cellular processes, including proliferation, differentiation and migration. They signal through heteromeric complexes consisting of type I and type II transmembrane receptor serine kinases [5] . Upon activation, type I receptors associate with and activate Smad2 and/or Smad3, two mediators of the Smad protein family. Activated Smad2 and/or Smad3 associate with the common mediator Smad4 and translocate to the nucleus, where Smad protein complexes participate in transcriptional activation of target genes. The TGF-β/Smad signaling cascade contains an autoinhibitory feedback loop involving Smad7 [6, 7] . Smad7 interacts with ligand-activated type I receptors and interferes with receptor binding and phosphorylation of substrate Smads [8] . The Smad7 gene is highly regulated, e.g. following incubation with a variety of cytokines like TNF-α, IFN-γ, EGF and TGF-β itself [9] [10] [11] [12] . Paracrine and autocrine stimulation of HSCs by TGF-β is a prerequisite for HSC activation and ECM deposition in damaged liver. TGF-β signaling is modulated during transdifferentiation of primary cultured cells [13] . Quiescent HSCs (2 days in culture) are sensitive to exogenous TGF-β, display Smad2/3 phosphorylation, binding to and activation of a Smad binding element (SBE) containing genes and transiently induce Smad7 expression [14] . In contrast activated HSCs (7 days in culture) are not equally responsive to TGF-β [15] . Furthermore, increased expression of TGF-β and constitutively phosphorylated Smad3 in activated HSCs indicate autocrine stimulation [16] [17] [18] [19] . Since TGF-β also induces Smad7 expression in quiescent HSCs, a tightly controlled TGF-β signaling is anticipated, whereas lack of Smad7 expression in autocrine activated MFBs could be relevant for the pathogenesis of progressive liver fibrosis. This assumption is substantiated by the findings that constitutive expression of Smad7 in HSCs completely abrogates transdifferentation to MFBs and reduces bile duct ligation (BDL)-dependent liver fibrosis in rats [20] . The role of TGF-β signaling in hepatocytes during chronic liver damage is yet not clear: Suppression of growth, structure and function of this cell type as well as induction of apoptosis is suggested, but molecular details are not thoroughly delineated [21] . Aim of the current study was to add in vivo data highlighting the previously reported predominant role of Smad3 -dependent TGF-β signaling in fibrogenesis. In a rat cholestasis model, fibrotic tissue is characterized by increased Smad3 signaling, as indicated by phosphoSmad3 analysis in total liver tissue lysates and nuclear Smad3 staining in hepatocytes surrounding fibrotic lesions. Unexpectedly, there is a progressive increase in intrahepatic Smad7 expression, which was mainly localized to HSCs.
Materials and methods

Materials
Taq polymerase and α-32 PdCTP were from Amersham/Pharmacia (Freiburg, Germany). Oligonucleotides were from MWG Biotech (Ebersberg, Germany).
Induction of fibrosis in rats
Male Sprague-Dawley rats (300 g body weight, HarlanWinkelmann, Borchen, Germany) were kept temperature controlled (22°C) with a 12 h light/dark cycle and fed ad libitum with standard chow. Animals had free access to tap water. The common bile duct was located through a midline incision and double ligated near the liver hilus with transection between the ligatures [22] . Rats were anaesthetised with 100 mg/kg ketamine (Sanofi-ZEVA, Düsseldorf, Germany) and 6 animals were sacrificed on days 7 
Hydroxyproline measurement
Frozen liver tissue was hydrolyzed in 2.0 ml 6 N HCl for 3 hrs at 130°C. The solution was neutralized to pH 7.0 with 2.5 N NaOH and diluted 40-fold with deionized H 2 O. 2 ml diluted solution were mixed with 1.0 ml 0.05 M chloramine T solution and incubated for 20 minutes at room temperature. 1 ml 3.15 M perchloric acid was added and the solution was incubated for 5 minutes at room temperature. 1 ml 20% p-dimethylaminobenzaldehyde was added and the solution was incubated for 20 minutes at 60°C. Absorbance was determined at 557 nm, and hydroxyproline was calculated by comparison to a standard curve [23] .
Isolation of total RNA, mRNA and Northern blot analysis
Tissue samples were homogenized in TRIZOL Reagent (GIBCO BRL, Eggenstein, Germany; 1 ml/100 mg tissue) using the UltraTurrax (IKA, Staufen, Germany). mRNA was isolated using the Oligotex mRNA Midi Kit (Qiagen; 0.04-0.05 mg mRNA per mg total RNA). For Northern blot analysis, one third of mRNA preparations from three different animals were pooled, electrophoresed in 1% agarose formaldehyde gels and transferred to GeneScreen nylon membranes (NEN DuPont, Boston, USA). After ultraviolet crosslinking, blots were hybridized as described [15] . A 610 bp Eco RI/Not I fragment was generated from plasmid pcDNA3.1-FlagSmad7 [7] , kindly provided by Peter ten Dijke. To detect GAPDH a 1.4-kb DNA probe containing rat GAPDH cDNA fragment was created from pBluGAP [24] by Eco RI digestion. The fragments were gel purified and labeled with 32 P-dCTP using a random primer labeling kit from Gibco BRL (Rockville, MD, USA).
Immunoblotting
Lysates from liver tissue were prepared with RIPA buffer (1 x TBS, 1 % Nonidet P-40, 0.5 % sodium deoxycholate, 0.1 % SDS); Protease Inhibitor Mix (Roche) and Phosphatase Inhibitor Mix (Sigma, München, Germany) were added. Lysates were cleaned and enriched with the Protein Clean Up and Enrichment Kit from Pierce (Bonn, Germany). 5 to 8 μg protein lysates from each of 6 animals representing one experimental group were pooled, separated by 8% SDS PAGE and transferred to 0.45 μm nitrocellulose membranes (Protran BA 85; Schleicher & Schüll, Germany). Nonspecific binding was blocked by 5% milk powder in TBST overnight at 4°C followed by incubation with primary antibodies (diluted at 1:2.000 in 2.5 % milk powder in TBST) overnight at 4°C. Blots were washed two times in TBS/0.05 % Tween20 (BioRad, München, Germany) and three times in TBS for 5-10 min each. The secondary anti rabbit horseraddish peroxidase antibody (stock solution: 400 μg/ml; 1:50.000; Santa Cruz Biotechnology, CA, USA) was incubated for one hour at room temperature followed by five wash steps as described above. Bound antibodies were detected with Supersignal West Dura (Pierce) for 5 min and subsequent evaluated with a LumiImager (Roche). Antibodies used were murine monoclonal anti-α SMA (Roche); monoclonal anti Smad4, polyclonal antiSmad2 and Smad7 (Santa Cruz); anti Smad3 (Zytomed, Berlin, Germany); phospho-Smad2 and phospho-Smad3, kindly provided from P. ten Dijke, Leiden Univ Medical Center.
Immunohistochemistry
The liver was perfused under low pressure via the portal vein and thereafter excised, cut into small pieces, fixed in 4% paraformaldehyde in PBS, 10% formalin, and embedded in paraffin. 2 μm sections were deparaffinized and incubated for 30 min with hyaluronidase (1 mg/ml) in 100 mM Na-acetate, 150 mM NaCl, pH 5.5 for antigen demasking. Sections were then permeabilised on ice with 0.1% Triton X-100 in prechilled 0.1% Na-citrate buffer and in aceton (-20°C) for 90 sec. Antibodies used were monoclonal anti-α SMA (Roche), diluted 1:2.000. FITC labeled rabbit antimouse antibody (Santa Cruz) was used as secondary antibody at 1:200.
Picro sirius red staining was performed with 5 μm sections in staining solution (0.1g Sirius red, Polysciences, Eppelheim, Germany, in 100 ml picric acid) for 1h. Haematoxylin-Eosin and Ladewig stainings were performed according to standard procedures.
Results
Smad3 signaling is induced in bile duct ligation dependent fibrosis in rats
Histological evaluation of liver specimens from rats treated with BDL showed time-dependent increase in centrilobular and periportal ECM deposition. Fig. 1 displays representative liver samples from control and BDL animals taken at different time points after initiation of cholestasis and stained with picro sirius red to demonstrate collagen deposition. Correspondingly, hydroxyproline in total liver lysates was increased in BDL-rats ( Fig. 2A) . To further quantify the effects that BDL has on liver functions, serum concentrations of bilirubin and liver enzymes were determined ( B-D). Within one week hydoxyproline levels were increased and remained within the same range for the whole experimental setting of 5 weeks. Similar rapid elevations and time courses were apparent for the other parameters, indicating progressive damage and upregulated collagen synthesis. Western blots from liver lysates and immunohistochemistry data from liver tissue sections demonstrate upregulated α-SMA expression with duration of cholestasis, indicating HSC proliferation and transdifferentiation (Fig. 3) . Liver lysates from 6 animals treated for 2 and 4 weeks with BDL and from 4 sham operated controls were pooled and examined with phospho-Smad specific antibodies to test for activation of the TGF-β pathway (Fig. 4) . Primary cultured HSCs from healthy rats at day 2 in culture were serum starved for 8 hrs and then treated for 1 h with 5 ng/ml TGF-β1. Corresponding lysates were used as positive control for Smad2/3 Cterminal phosphorylation. Our data display activation of TGF-β/Smad3 signaling in damaged tissue when compared to controls, whereas Smad2 phosphorylation was only slightly increased. Upregulated Smad3 phosphorylation was not accompanied by increased Smad3 expression.
Immunostainings with an antibody detecting selectively Smad3 show nuclear localization of Smad3 in nonparenchymal and virtually all parenchymal cells in fibrotic lesions of BDL damaged livers, whereas control animals were completely negative (Fig. 5 ).
Smad7 expression is continuously increased during bile duct ligation dependent fibrogenesis
Next, the expression of Smad4 and Smad7 mRNA in liver lysates was quantified. For Smad4, we used Cybergreen incorporation to measure real time amplification with rat Smad4 specific primers (Fig.  6 A) . These data rather indicate a downregulation of Smad4 mRNA with cholestasis, at the same time no change of Smad4 protein levels was observed by Western blotting (Fig. 6 B) . In contrast, Smad7 expression levels increased over time after BDLinduced cholestasis, as measured by RT-PCR with rat Smad7 specific primers (Fig. 7 A) . The data were validated by Northern blotting with mRNA that was hybridized with a specific Smad7 cDNA probe (Fig. 7 B) . Immunostainings of liver sections demonstrate that Smad7 is present in nonparenchymal cells, probably representing regulation of TGF-β signaling in activated proliferating HSCs (Fig. 5 ).
Discussion
As a consequence of chronic liver diseases deposition of ECM occurs with profound changes of the liver architecture [2] . Various cytokines are involved in disease pathogenesis. In particular, TGF-β1 is overexpressed in nonparenchymal cells of cirrhotic liver and plays a pivotal role in cirrho- Fig. 4 Phosphorylation of Smad3 is induced in total liver lysates of rats treated with bile duct ligation. A mixture of total liver protein lysates pooled from 6 animals (8 μg from each sample, 48 μg in total) at each time point were analyzed by SDS-PAGE followed by Western blotting and immunodetection using specific antisera, as indicated. Quiescent (2 days) primary cultured rat hepatic stellate cells (HSCs), treated with 5 ng/ml TGF-β for 1 h were used as positive control for Smad phosphorylation. Parallel blots were probed in presence of blocking peptides, to which the antisera were originally raised, resulting in blank lanes (not shown), or with Smad2/3-specific antisera as indicated, to demonstrate relative Smad protein expression. Blots were reprobed with a monoclonal anti-b-actin antibody to confirm equal protein loading (not shown).
sis development by stimulating activation of HSCs [4] . Furthermore, TGF-β inhibits hepatocyte proliferation and contributes to impaired hepatic regeneration. Therapeutic trials designed to inactivate TGF-β in liver cells blunted fibrogenesis, confirming the relevance of TGF-β signaling in chronic liver disease [20, [25] [26] [27] [28] . We and others have investigated molecular details of TGF-β signaling in primary cultured HSCs. Quiescent cells (2 days in culture) are sensitive to exogenous TGF-β and respond with Smad2/3 phosphorylation [14] . At this stage, Smad7 represents one of the target genes, initiating a negative feedback mechanism and leading to a fine tuning of TGF-β signaling [15] . Activated HSCs (7 days in culture) display a distinct TGF-β signalling response. These cells are stimulated autocrine by endogenously produced and secreted TGF-β and do not respond with Smad7 upregulation after exogenous addition of TGF-β1 [13] . These cells do not express Smad7 and overexpression of Smad7 by adenoviral infection completely abrogates the transdifferentiation process [20] . Similar findings were reported when comparing TGF-β signaling in acute and chronic rat liver injury [29] . Acute CCl 4 intoxication led to Smad2 phosphorylation and induction of Smad7 expression in HSCs, whereas chronic damage induced by CCl 4 treatment 3 times per week 6 Sybr-Green real time quantitative RT-PCR displayed a slightly downregulation of Smad4 mRNA expression in BDL treated rat liver recovering levels trending upward in proportion to the duration of chronic injury . Total RNA was purified from whole liver and 1 mg RNA was reverse transcribed to cDNA and real time quantitative RT-PCR was undertaken using the Light Cycler (Roche) with the QuantiTec SYBR Green PCR Kit(Qiagen, Hilden, Germany) according to the manufacturers protocol. As a standard reaction, cDNA corresponding to 200, 100, 50 or 25 ng total RNA of a mixture of all samples was exampled. Subsequently, cDNAs of different samples were analysed, each corresponding to 100 ng reverse transcribed total RNA. The results were interpreted according to the manufacturers instruction. Cycling steps were as follows 95°C, 15 minutes;1 cycle and 94°C, 15 sec;50°C, 20 sec; 72°C, 20 sec;45 cycles. The following two primer sequenzes rat Smad4 for 5´-GATAGCGTCTGTGTGAACC-3´; rat Smad4 rev 5´-GTACTGGTGGCATTA-GACTC-3´ were used. The figure is representative for three independent experiments (mean values ± SD of n = 2).
Fig. 7
Sybr-Green real time quantitative RT-PCR displays increased mRNA expression of antagonistic Smad7 in BDL treated rat liver, levels trending upward in proportion to the duration of chronic injury. Total RNA was purified from whole liver and 1 mg RNA was reverse transcribed to cDNA and real time quantitative RT-PCR was undertaken using the Light Cycler (Roche) with the QuantiTec SYBR Green PCR Kit(Qiagen, Hilden, Germany) according to the manufacturers protocol. As a standard reaction, cDNA corresponding to 200, 100, 50 or 25 ng total RNA of a mixture of all samples was exampled. Subsequently, cDNAs of different samples were analysed, each corresponding to 100 ng reverse transcribed total RNA. The results were interpreted according to the manufacturers instruction. Cycling steps were as follows 95°C, 15 minutes;1 cycle and 94°C, 15 sec; 50°C, 20 sec; 72°C, 20 sec; 45 cycles. The following two amplification primers ( rat Smad 7 for: 5`-GGAGTCCTTTCCTCTCTC-3`; rat Smad 7 rev: 5`GGCTCAATGAGCATGCT-CAC-3`,MWG Biotech, Berlin, Germany) were used. The figure is representative for three independent experiments (mean values ± SD of n = 2). [18, 19] . Similar data were reported in primary cultured HSCs, which display predominant Smad2 signaling at day 2 in culture and a modulation of TGF-β signaling to the Smad3 pathway primarily in transdifferentiated MFBs [32] . In addition, increased phosphorylation of the linker region by the p38 MAPK pathway was described in primary cultures of HSCs and the authors propose that, as HSCs become fully differentiated to MFBs, the TGF-β RI-mediated Smad3 signal decreases and a p38 MAPK-mediated Smad3 signal predominates with the sequela of excess ECM synthesis and deposition [33] . Our data from BDL rats further support a prominent role of this pathway, since Smad3 and not Smad2 phosphorylation is enhanced after liver damage as assessed by Western blotting using whole liver lysates and phospho-Smad specific antisera. Interestingly, immunohistochemical data reveal that significant Smad3 signaling can be observed in hepatocytes from fibrotic lesions, indicating upregulated TGF-β signaling in hepatocytes during liver damage. It is hypothesized that TGF-β signaling in hepatocytes is directed to blunting liver regeneration by proliferation inhibition and/or apoptosis induction. In a recent study with Bcl-xL knock out mice, persistent apoptosis of hepatocytes was sufficient to induce fibrotic lesions in liver tissue and suggests a mechanistic link between apoptosis and fibrosis [34] . Further, generation of ECM producing interstitial fibroblasts from hepatocytes by EMT [34] and participation of TGF-β in such a process is conceivable. In summary, the presented in vivo data regarding TGF-β signaling in chronic liver disease due to cholestasis further confirm a prominent role for Smad3, occurring predominantly in hepatocytes of fibrotic lesions. Unexpectedly, Smad7 expression is continuously increasing in nonparenchymal cells during cholestasis. These data indicate, that a functional negative regulation of TGF-β signaling in HSCs by Smad7 is not sufficient to blunt fibrogenesis in vivo and favor an important role of Smad3 activation in hepatocytes.
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